Anacetrapib(MK0859) [875446-37-0]

Biorbyt

Anacetrapib(MK0859) [875446-37-0]

16

875446-37-0

Research Use Only

C30H25F10NO3

637.5084

Anacetrapib (MK0859) is a potent, selective, reversible rhCETP and mutant CETP(C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM, increases HDL-C and decreases LDL-C, does not increase aldosterone or blood pressure. Phase 3.

FC(C1C([H])=C(C(F)(F)F)C([H])=C(C=1[H])[C@]1([H])[C@]([H])(C([H])([H])[H])N(C(=O)O1)C([H])([H])C1C([H])=C(C(F)(F)F)C([H])=C([H])C=1C1C(=C([H])C(=C(C([H])(C([H])([H])[H])C([H])([H])[H])C=1[H])F)OC([H])([H])[H])(F)F

12352200